Montana Lets You Gamble Your Ears on Antihistamines and Sounds

KEY POINTS

•Niklas Anzinger, founder of Infinita City Inc., helped draft Montana’s 2025 right-to-try law to expand access to experimental treatments.
•A private review board owned by Anzinger’s company charges $12,500 fees and recently approved a hearing loss treatment combining antihistamines and sound therapy.
•Montana aims to create a medical tourism hub like Próspera in Honduras, backed by investors such as Peter Thiel and Marc Andreessen.

In Montana, a new 'right-to-try' law champions experimental drugs for anyone with cash and courage, even if the treatment only survived Phase 1 trials proving it probably won't kill you. Enter Niklas Anzinger, a 37-year-old German biotech libertarian and founder of Infinita City Inc., whose private Caribbean biotech paradise Próspera—funded by Peter Thiel and Marc Andreessen—offers anti-aging startups a regulation-free playground. Montana, inspired to become a medical tourism hotspot rivaling gene therapy resorts in Honduras and psychedelic jaunts in Mexico, just approved a $12,500 application board fee to gamble on hearing loss cures involving off-label antihistamines paired with some fancy sound therapy from Denver. Patients can get excited once the state issues licenses—for now, it's like buying concert tickets to a show that hasn't quite happened yet.